PixarBio Corporation CEO Frank Reynolds to Present NeuroRelease a Morphine Replacement, Non-Opiate, Non Addictive Pain Treatment at the 2017 NobleCon13 Investor Conference in Boca Raton, FL on Monday, January 30, 2017 )–PixarBio Corporation developers of NeuroReleaseTM, a morphine replacement, non-opiate/opioid, non-addictive pain treatment with… )–Mercantil Commercebank, the fourth largest commercial bank headquartered in Florida and among the top 2% of banks nationally ranked by asset size, has changed i… Global Point-of-Care Testing Market Trends and Forecast to 2024: Market is Expected to Reach USD 38.2 Billion by 2024, at a CAGR of 9.5% – Research and Markets )–Research and Markets has announced the addition of the “Global Point-of-Care Testing Market – Trends and Forecast To 2024” report to their offering.